In a troubling development that highlights how markets can predict public health outcomes, dental care stocks surged following Robert F. Kennedy Jr.’s nomination as Health and Human Services Secretary, as investors bet on increased tooth decay if his anti-fluoride agenda succeeds.

Companies like Henry Schein, which supplies dental products, saw their stock jump over 5% – their biggest gain since 2022. Fellow dental product manufacturers Dentsply Sirona and Envista also rose in trading, marking a clear market response to Kennedy’s potential impact on public health policy.

The market surge followed Kennedy’s statement on social media that “the Trump White House will advise all U.S. water systems to remove fluoride from public water.” While the stock market isn’t taking political sides, it is following decades of established science showing fluoride’s effectiveness in preventing tooth decay.

According to the Centers for Disease Control and Prevention (CDC), fluoridated water helps strengthen tooth surfaces, making them more resistant to decay. The recommended concentration is minimal – just 0.7mg of fluoride per liter of water, equivalent to about three drops in a 55-gallon barrel. This public health measure currently saves Americans an estimated $6.8 billion in dental expenses annually, or approximately $32 per person for 211 million people.

As noted by Don Bilson, Gordon Haskett’s head of event-driven research, “The thought here is RFK will bring to HHS a voice that is in favor of reducing, or eliminating, the amount of fluoridation that is added to drinking water. This will, in turn, lead to an acceleration of tooth decay and more dental visits.”

Though the federal government cannot directly mandate fluoride removal – as state and local governments make these decisions – Kennedy’s influence could lead conservative-leaning communities to abandon this crucial public health measure. This creates a troubling scenario where dental health could become increasingly divided along political lines, with some areas maintaining fluoridation while others face rising dental problems.

The American Dental Association strongly supports community water fluoridation, stating that “Seventy years of research, thousands of studies and the experience of more than 210 million Americans tell us that water fluoridation is effective in preventing cavities and is safe for children and adults.”

The financial implications extend beyond immediate dental costs. Communities that remove fluoride can expect higher insurance premiums as insurers adjust for increased cavity rates. Working families in these areas would face both higher insurance costs and increased out-of-pocket expenses for dental work.

While dental product companies may see short-term profits, the broader economic impact on American families could be substantial. Currently, 72% of the U.S. population served by community water systems receives fluoridated drinking water – a public health achievement that has particularly benefited children and populations without regular access to dental care.

The market reaction to Kennedy’s nomination wasn’t limited to dental stocks. As Gordon Haskett’s Bilson pointed out, while dental stocks were “spared,” pharmaceutical names faced pressure due to Kennedy’s vaccine skepticism, and processed food stocks declined as traders anticipated increased scrutiny of so-called junk food.

It’s worth noting that any regulatory changes would likely take years to implement, and as Bilson observed, drinking water regulation falls more under the Environmental Protection Agency’s purview than Health and Human Services. However, the market’s immediate response signals serious concerns about the potential public health implications of anti-fluoride policies.

The stock market’s reaction serves as a stark warning: removing fluoride from drinking water isn’t just contrary to established science – it’s a policy that could create unnecessary financial burdens for American families while generating profits for dental care providers. As this debate continues, the market’s message is unmistakable: betting against public health measures means betting on more suffering – and higher profits for those who treat it.